Medico Remedies (MEDICO) Share Price Falls 10.80% Today; What the Decline Signals
- September 1, 2026
- Posted by: Harsh Piplani
- Category: News
Medico Remedies Share Price fell to Rs 37.91 on 01 September 2026, down 10.80% for the day, taking the company’s market capitalisation to Rs 352.68 crore. The Micro Cap pharmaceutical stock opened at Rs 41.99, touched a high of Rs 42.54 and slipped to an intraday low of Rs 37.84, showing a sharp same-day decline in price action.
The supplied data confirms the move but does not identify any company-specific catalyst behind it. That means the current discussion is centred on observable numbers: intraday trading behaviour, valuation, profitability, and how the company compares with the broader Healthcare sector and the Pharmaceuticals & Drugs industry benchmark.
For readers tracking Medico Remedies Share Price today, the key question is not only how far the stock fell, but also whether the underlying ratios present a different picture from the day’s market action. Univest data suggests the stock is small by market value, yet its return ratios are stronger than several benchmark averages in its industry group.
Medico Remedies (MEDICO) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 37.91 |
| Previous Close | Rs 42.5 |
| Today's Move | -Rs 4.59 (-10.8%) |
| Open | Rs 41.99 |
| High | Rs 42.54 |
| Low | Rs 37.84 |
| Turnover | Rs 0.1 crore |
| Market Capitalisation | Rs 352.68 crore |
| Market Cap Category | Micro Cap |
Medico Remedies Share Price moved lower from the start of the session. The stock opened at Rs 41.99 versus the previous close of Rs 42.50, briefly traded at Rs 42.54, and then declined to Rs 37.84 before trading at Rs 37.91 at the supplied timestamp. With the price remaining close to the day low, the session reflected sustained weakness rather than a brief intraday dip.
The absolute change was Rs 4.59, equal to a 10.80% decline. Turnover stood at Rs 0.10 crore, which is worth noting because small-cap counters can sometimes record large percentage moves even on modest traded value. In that context, today’s move says more about market behaviour in a Micro Cap stock than about a confirmed business development, because no cause is provided in the source data.
Medico Remedies (MEDICO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 352.68 crore |
| P/E Ratio | 25.53x |
| P/B Ratio | 4.52x |
| ROE | 17.58% |
| ROCE | 21.65% |
| EPS | Rs 1.66 |
| Book Value Per Share | Rs 9.4 |
| Dividend Yield | 0% |
Medico Remedies Share Price is under pressure today, but the basic financial picture is not defined by price alone. The company trades at a P/E ratio of 25.53 and a P/B ratio of 4.52. Return ratios are stronger than the broad industry averages available in the benchmark set, with ROE at 17.58% and ROCE at 21.65%.
EPS stands at Rs 1.66 and book value per share at Rs 9.40, while dividend yield is 0. Taken together, these figures suggest the stock is being watched mainly for valuation and profitability context rather than dividend support. Since the company’s market cap is Rs 352.68 crore, it remains firmly in the Micro Cap category, a segment where trading swings can be sharper than in larger businesses.
This is why the current setup is mixed. On one side, the share price has weakened sharply in a single session. On the other, the reported profitability ratios are not weak versus the industry data supplied. That contrast is one reason Medico Remedies Share Price remains in focus even without a stated trigger in the source material.
Technical Snapshot
From the supplied technical indicators, RSI stands at 44.88, while the 50-day and 200-day moving averages are Rs 44.23 and Rs 44.20 respectively. With the current price at Rs 37.91, the stock is below both moving-average reference points in the data provided. These are descriptive indicators only and do not explain the cause of the move, but they help frame the current weakness in context.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 25.53x |
| Benchmark Median P/E | 30.92x |
| Benchmark Average P/E | 48.02x |
| Benchmark P/E Range | 3.87x to 667.16x |
| Company P/B Ratio | 4.52x |
| Benchmark Median P/B | 2.88x |
| Benchmark Average P/B | 4.34x |
| Company ROE | 17.58% |
| Benchmark Median ROE | 11.81% |
| Benchmark Average ROE | 11.21% |
| Company ROCE | 21.65% |
| Benchmark Median ROCE | 13.65% |
| Benchmark Average ROCE | 13.76% |
| Company Market Capitalisation | Rs 352.68 crore |
| Benchmark Median Market Cap | Rs 683.05 crore |
| Benchmark Average Market Cap | Rs 14,252.9 crore |
Medico Remedies belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. In that benchmark universe of 201 companies, its P/E ratio of 25.53 is below the median of 30.92 and the average of 48.02. That suggests the earnings multiple is not above broader industry norms in the supplied dataset.
On the other hand, its P/B ratio of 4.52 is above the benchmark median of 2.88 and slightly above the average of 4.34. Profitability is stronger in relative terms: ROE of 17.58% compares with a benchmark median of 11.81% and average of 11.21%, while ROCE of 21.65% is above the benchmark median of 13.65% and average of 13.76%.
The market-cap comparison also matters. At Rs 352.68 crore, the company is smaller than the benchmark median market cap of Rs 683.05 crore and far below the benchmark average of Rs 14,252.9 crore. So the sector view is straightforward: Medico Remedies is a smaller listed pharma company with stronger reported return ratios than many peers, but with a scale that can make the stock more volatile.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,60,696.31 | 38.8 | 5.43 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,46,062.83 | 83.91 | 13.89 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,91,515.22 | 86.82 | 21.1 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,18,403.7 | 25.69 | 4.3 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,14,554.33 | 33.94 | 3.25 | 11.83 | 16 |
Peer data shows that Medico Remedies sits at a very different scale from major listed pharma names. Its P/E of 25.53 is close to Zydus Lifesciences at 25.69, below Sun Pharma at 38.80, below Cipla at 33.94, and far below Divi’s Laboratories and Torrent Pharmaceuticals, which trade at 83.91 and 86.82 respectively.
Its P/B ratio of 4.52 is below Sun Pharma, Divi’s and Torrent, but above Zydus and Cipla. On profitability, ROE of 17.58% is above Sun Pharma, Divi’s and Cipla, though below Zydus and Torrent. ROCE of 21.65% is above Sun Pharma, Torrent and Cipla, and slightly above Zydus while close to Divi’s.
The scale gap remains the clearest difference. Medico Remedies has a market cap of Rs 352.68 crore, versus more than Rs 1,14,554 crore for the smallest company in this peer table. That does not make the comparison invalid, but it does mean Medico Remedies Share Price can move very differently from these larger companies even when some valuation or return ratios look comparable.
Why Investors Are Watching Medico Remedies
- Medico Remedies Share Price fell 10.80% to Rs 37.91 in a single session.
- The stock stayed close to its day low of Rs 37.84 at the supplied timestamp.
- P/E at 25.53 is below the same-industry median of 30.92.
- ROE of 17.58% and ROCE of 21.65% are above benchmark medians and averages.
- The company’s Rs 352.68 crore market cap places it in the Micro Cap category, where volatility can be sharper.
About Medico Remedies
Medico Remedies operates in the Healthcare sector and is classified under Pharmaceuticals & Drugs. Based on the supplied benchmark data, it is part of a 201-company industry universe used for valuation and profitability comparison. Its current size places it among the smaller listed names in the space.
Track Medico Remedies Share Price on Univest
Use Medico Remedies (MEDICO) live share-price page,Univest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Medico Remedies Share Price falling today?
Ans. The stock is down 10.80% from Rs 42.50 to Rs 37.91 in the supplied session data. However, the source data does not provide a company-specific reason for the decline. The previous close was Rs 42.5.
What is Medico Remedies Share Price today?
Ans. The supplied current price is Rs 37.91. The stock opened at Rs 41.99, recorded a high of Rs 42.54 and a low of Rs 37.84. The previous close was Rs 42.5.
How much did Medico Remedies stock fall today?
Ans. The stock fell by Rs 4.59, or 10.80%, compared with its previous close of Rs 42.50. The previous close was Rs 42.5. The stock moved 10.8% lower during the session.
What is the market capitalisation of Medico Remedies?
Ans. Medico Remedies has a market capitalisation of Rs 352.68 crore and is classified as a Micro Cap stock. The company operates in the Healthcare sector. Its P/E ratio is 25.53x.
Is Medico Remedies expensive on a P/E basis?
Ans. Its P/E ratio is 25.53, which is below the industry median of 30.92 and average of 48.02 in the supplied Pharmaceuticals & Drugs benchmark data. The company trades at a P/E ratio of 25.53x.
How does Medico Remedies compare on profitability?
Ans. ROE is 17.58% and ROCE is 21.65%. Both are above the industry benchmark medians of 11.81% and 13.65% respectively. ROE stands at 17.58%. ROCE stands at 21.65%. The relevant peer median ROE is 11.81%.
How does Medico Remedies compare with large pharma peers?
Ans. It is much smaller by market cap than Sun Pharma, Divi’s, Torrent, Zydus and Cipla. Its P/E is closest to Zydus, while its ROCE compares favourably with several peers in the provided table.
